Order Article Reprints

Besse HC, Chen Y, Scheeren HW, Metselaar JM, Lammers T, Moonen CTW, Hennink WE, Deckers R. A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase. Pharmaceutics. 2020; 12(6):536. https://doi.org/10.3390/pharmaceutics12060536

Besse, Helena C., Yinan Chen, Hans W. Scheeren, Josbert M. Metselaar, Twan Lammers, Chrit T. W. Moonen, Wim E. Hennink, and Roel Deckers. 2020. "A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase" Pharmaceutics 12, no. 6: 536. https://doi.org/10.3390/pharmaceutics12060536

Besse, H. C., Chen, Y., Scheeren, H. W., Metselaar, J. M., Lammers, T., Moonen, C. T. W., Hennink, W. E., & Deckers, R. (2020). A Doxorubicin-Glucuronide Prodrug Released from Nanogels Activated by High-Intensity Focused Ultrasound Liberated β-Glucuronidase. Pharmaceutics, 12(6), 536. https://doi.org/10.3390/pharmaceutics12060536